Autres langues Vivos Inc.

Actions

RDGL

US92858K2042

Temps Différé OTC Markets Autres places de cotation 18:34:14 17/05/2024			Varia. 5j.	Varia. 1 janv.
0,1725 ^USD	-6,30 %		-13,75 %	+138,59 %

09/05	Vivos Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
18/03	Vivos Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation	20/12
Vivos Inc. Announces Radiogel(TM) Precision Radionuclide Therapy(TM) Receives FDA Breakthrough Device Designation	20/12
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11
Vivos : Quarterly Progress Report - Form 8-K	11/10/23
Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics	07/08/23
Vivos Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/08/23
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	04/05/23
Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	04/05/23
VIVOS INC : Unregistered Sale of Equity Securities (form 8-K)	02/05/23
VIVOS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	01/03/23
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/03/23
Vivos Inc. Auditor Raises 'Going Concern' Doubt	01/03/23
Vivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapy	11/01/23
Vivos Inc Files A New Patent on Alternate Particles for Precision Radionuclide Therapy	11/01/23
Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment	03/01/23
Vivos Inc. Files New Patent on Precision Radionuclide Therapy Support System Equipment	03/01/23
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	19/10/22
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	19/10/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Vivos Inc.

Actions

RDGL

US92858K2042

Autres langues

Filtres